{"DataElement":{"publicId":"7341794","version":"1","preferredName":"Hematopoietic Cell Transplantation Or Cellular Therapy Infusion Procedure Primary Indication Type","preferredDefinition":"A description of the primary indication for the hematopoietic cell transplant or cellular therapy infusion.","longName":"7341760v1.0:7341791v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"7341760","version":"1","preferredName":"Hematopoietic Cell Transplantation Or Cellular Therapy Infusion Procedure Primary Indication","preferredDefinition":"A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Utilization of specific cells, modified or not, for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy._Any form of treatment that is introduced into the body via a blood vessel, a muscle, or the spinal cord._Occurring first in time or sequence; original; of greatest rank or importance or value._A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).","longName":"7341758v1.0:6662739v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"7341758","version":"1","preferredName":"Hematopoietic Cell Transplantation Or Cellular Therapy Infusion Procedure","preferredDefinition":"A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases.:An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:Utilization of specific cells, modified or not, for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy.:Any form of treatment that is introduced into the body via a blood vessel, a muscle, or the spinal cord.","longName":"C15431:C37998:C70601:C15388","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic Cell Transplantation","conceptCode":"C15431","definition":"A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Cellular Therapy","conceptCode":"C70601","definition":"Utilization of specific cells, modified or not, for treatment of diseases. Donor lymphocyte infusion is a type of cellular therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Infusion Procedure","conceptCode":"C15388","definition":"Any form of treatment that is introduced into the body via a blood vessel, a muscle, or the spinal cord.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8B28FC9-AE17-770B-E053-4EBD850AF63E","latestVersionIndicator":"Yes","beginDate":"2020-06-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-23","modifiedBy":"ONEDATA","dateModified":"2020-06-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6662739","version":"1","preferredName":"Primary Indication","preferredDefinition":"Occurring first in time or sequence; original; of greatest rank or importance or value.:A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).","longName":"C25251:C41184","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indication","conceptCode":"C41184","definition":"A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"83827884-9ACA-67DE-E053-F662850A7E9C","latestVersionIndicator":"Yes","beginDate":"2019-03-07","endDate":null,"createdBy":"MALUMK","dateCreated":"2019-03-07","modifiedBy":"ONEDATA","dateModified":"2019-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8B28FC9-AE25-770B-E053-4EBD850AF63E","latestVersionIndicator":"Yes","beginDate":"2020-06-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-23","modifiedBy":"MALUMK","dateModified":"2020-07-30","changeDescription":"Released. 07/30/2020 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7341791","version":"1","preferredName":"Infusion Procedure Indication Type","preferredDefinition":"Any form of treatment that is introduced into the body via a blood vessel, a muscle, or the spinal cord._A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication)._Something distinguishable as an identifiable class based on common qualities.","longName":"7341791v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"3126125","version":"1","preferredName":"Other","longName":"3126125","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D01180C-814A-B8B4-E040-BB89AD432507","latestVersionIndicator":"Yes","beginDate":"2010-08-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-08-04","modifiedBy":"KUMMEROA","dateModified":"2023-03-07","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":"2023.3.7 Alt VM added per ticket request CADSR0002119. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A8B057E2-A82C-59B1-E053-4EBD850AFE86","beginDate":"2020-06-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-23","modifiedBy":"ONEDATA","dateModified":"2020-06-23","deletedIndicator":"No"},{"value":"Central nervous system event","valueDescription":"Central Nervous System Occurrence","ValueMeaning":{"publicId":"7341792","version":"1","preferredName":"Central Nervous System Occurrence","longName":"7341792","preferredDefinition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.: An instance of something happening, such as an event or incident.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System","conceptCode":"C12438","definition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Occurrence","conceptCode":"C25275","definition":"An instance of something happening, such as an event or incident.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8B057E2-A839-59B1-E053-4EBD850AFE86","latestVersionIndicator":"Yes","beginDate":"2020-06-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-23","modifiedBy":"ONEDATA","dateModified":"2020-06-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A8B057E2-A852-59B1-E053-4EBD850AFE86","beginDate":"2020-06-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-23","modifiedBy":"ONEDATA","dateModified":"2020-06-23","deletedIndicator":"No"},{"value":"Vaso-occlusive pain","valueDescription":"Vaso-Occlusive Crisis","ValueMeaning":{"publicId":"7341793","version":"1","preferredName":"Vaso-Occlusive Crisis","longName":"7341793","preferredDefinition":"An exacerbation of sickle cell disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vaso-Occlusive Crisis","conceptCode":"C122412","definition":"An exacerbation of sickle cell disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8B057E2-A85E-59B1-E053-4EBD850AFE86","latestVersionIndicator":"Yes","beginDate":"2020-06-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-23","modifiedBy":"ONEDATA","dateModified":"2020-06-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A8B057E2-A877-59B1-E053-4EBD850AFE86","beginDate":"2020-06-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-23","modifiedBy":"ONEDATA","dateModified":"2020-06-23","deletedIndicator":"No"},{"value":"Priapism","valueDescription":"Priapism","ValueMeaning":{"publicId":"3211382","version":"1","preferredName":"Priapism","longName":"3211382","preferredDefinition":"Persistent and usually painful erection that lasts for at least four hours, in the absence of physical or psychological stimulation. It may be caused by hematologic disorders including sickle cell disease and leukemia, spinal cord injuries, and medications.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Priapism","conceptCode":"C85022","definition":"Persistent and usually painful erection that lasts for at least four hours in the absence of physical or psychological stimulation, which can be caused by hematologic disorders, including sickle cell disease and leukemia, spinal cord injuries, and medications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-F607-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A8B057E2-A881-59B1-E053-4EBD850AFE86","beginDate":"2020-06-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-23","modifiedBy":"ONEDATA","dateModified":"2020-06-23","deletedIndicator":"No"},{"value":"Pulmonary hypertension","valueDescription":"Pulmonary Hypertension","ValueMeaning":{"publicId":"2946136","version":"1","preferredName":"Pulmonary Hypertension","longName":"2946136","preferredDefinition":"Increased pressure within the pulmonary circulation due to lung or heart disorder.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary Hypertension","conceptCode":"C3120","definition":"Increased pressure within the pulmonary circulation due to lung or heart disorder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746AE5AE-6AEF-370C-E040-BB89AD4351E3","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A8B057E2-A88B-59B1-E053-4EBD850AFE86","beginDate":"2020-06-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-23","modifiedBy":"ONEDATA","dateModified":"2020-06-23","deletedIndicator":"No"},{"value":"Acute chest syndrome","valueDescription":"Acute Chest Syndrome","ValueMeaning":{"publicId":"6680605","version":"1","preferredName":"Acute Chest Syndrome","longName":"6680605","preferredDefinition":"A vaso-occlusive crisis of the pulmonary vasculature occurring in patients with sickle cell disease. It is characterized by the presence of a new radiodensity on a chest radiograph accompanied by fever, cough, sputum production, dyspnea, or hypoxia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Chest Syndrome","conceptCode":"C138179","definition":"A vaso-occlusive crisis of the pulmonary vasculature occurring in patients with sickle cell disease. It is characterized by the presence of a new radiodensity on a chest radiograph accompanied by fever, cough, sputum production, dyspnea, or hypoxia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84AFF2ED-60A8-06D9-E053-F662850A627B","latestVersionIndicator":"Yes","beginDate":"2019-03-22","endDate":null,"createdBy":"MALUMK","dateCreated":"2019-03-22","modifiedBy":"ONEDATA","dateModified":"2019-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A8B057E2-A895-59B1-E053-4EBD850AFE86","beginDate":"2020-06-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-23","modifiedBy":"ONEDATA","dateModified":"2020-06-23","deletedIndicator":"No"},{"value":"Malignancy","valueDescription":null,"ValueMeaning":{"publicId":"2749852","version":"1","preferredName":"Malignant Neoplasm","longName":"2749852","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D47F93B-9A03-2D84-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9109C0C-1C9E-1B33-E053-731AD00AD7D7","beginDate":"2023-04-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-04-11","modifiedBy":"KUMMEROA","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"Bone marrow failure","valueDescription":null,"ValueMeaning":{"publicId":"3876601","version":"1","preferredName":"Bone Marrow Failure","longName":"3876601","preferredDefinition":"The inability of the bone marrow to produce hematopoietic elements.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bone Marrow Failure","conceptCode":"C80693","definition":"The inability of the bone marrow to produce hematopoietic elements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5AA7908-A143-DC7A-E040-BB89AD4319DD","latestVersionIndicator":"Yes","beginDate":"2013-09-05","endDate":null,"createdBy":"WONGW","dateCreated":"2013-09-05","modifiedBy":"KUMMEROA","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9109C0C-1C9F-1B33-E053-731AD00AD7D7","beginDate":"2023-04-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-04-11","modifiedBy":"KUMMEROA","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"Congenital immunodeficiency","valueDescription":null,"ValueMeaning":{"publicId":"13339629","version":"1","preferredName":"Congenital Combined Immunodeficiency","longName":"13339629v1.00","preferredDefinition":"A broad classification of inherited disorders presenting at birth that affect both the cell-mediated and humoral aspects of the immune response. Circulating numbers of B lymphocytes, T lymphocytes and NK cells are variable but where present do not function properly. Susceptibility to infection is the primary concern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Congenital Combined Immunodeficiency","conceptCode":"C27871","definition":"A broad classification of inherited disorders presenting at birth that affect both the cell-mediated and humoral aspects of the immune response. Circulating numbers of B lymphocytes, T lymphocytes and NK cells are variable but where present do not function properly. Susceptibility to infection is the primary concern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9109C0C-1C9D-1B33-E053-731AD00AD7D7","latestVersionIndicator":"Yes","beginDate":"2023-04-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-04-11","modifiedBy":"KUMMEROA","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9109C0C-1CA0-1B33-E053-731AD00AD7D7","beginDate":"2023-04-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-04-11","modifiedBy":"KUMMEROA","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"Fanconi anemia","valueDescription":null,"ValueMeaning":{"publicId":"5651022","version":"1","preferredName":"Fanconi Anemia","longName":"5651022","preferredDefinition":"A rare inherited disorder in which the bone marrow does not make blood cells. It is usually diagnosed in children between 2 and 15 years old. Symptoms include frequent infections, easy bleeding, and extreme tiredness. People with Fanconi anemia may have a small skeleton and brown spots on the skin. They also have an increased risk of developing certain types of cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fanconi Anemia","conceptCode":"C62505","definition":"An autosomal recessive genetic disorder characterized by bone marrow failure, skeletal abnormalities, and an increased incidence of the development of neoplasias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"479020AD-0CB9-3909-E053-F662850A62CA","latestVersionIndicator":"Yes","beginDate":"2017-02-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-02-02","modifiedBy":"KUMMEROA","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9109C0C-1CA1-1B33-E053-731AD00AD7D7","beginDate":"2023-04-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-04-11","modifiedBy":"KUMMEROA","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"Hemophagocytic lymphohistiocytosis","valueDescription":null,"ValueMeaning":{"publicId":"5527596","version":"1","preferredName":"Hemophagocytic Lymphohistiocytosis","longName":"5527596","preferredDefinition":"A rare but potentially life-threatening disorder characterized by the proliferation of histiocytes and macrophages and phagocytosis of red blood cells, white blood cells, and platelets. It may be inherited or secondary, due to infections, autoimmune disorders, or underlying malignancies. Signs and symptoms include fever, lymphadenopathy, hepatomegaly, splenomegaly, and pancytopenia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemophagocytic Lymphohistiocytosis","conceptCode":"C34792","definition":"A rare, but potentially life-threatening disorder, characterized by the proliferation of histiocytes and macrophages, and phagocytosis of red blood cells, white blood cells, and platelets. It may be inherited or secondary due to infections, autoimmune disorders, or underlying malignancies. Signs and symptoms include fever, lymphadenopathy, hepatomegaly, splenomegaly, and pancytopenia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F398FDB-132F-3260-E053-F662850A5E5F","latestVersionIndicator":"Yes","beginDate":"2016-10-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-19","modifiedBy":"KUMMEROA","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9109C0C-1CA2-1B33-E053-731AD00AD7D7","beginDate":"2023-04-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-04-11","modifiedBy":"KUMMEROA","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"Hemoglobinopathy","valueDescription":null,"ValueMeaning":{"publicId":"2593295","version":"1","preferredName":"Hemoglobinopathy","longName":"2593295","preferredDefinition":"A group of inherited disorders characterized by structural alterations within the hemoglobin molecule.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemoglobinopathy","conceptCode":"C3092","definition":"An inherited disorder characterized by structural alterations of a globin chain within the hemoglobin molecule.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28821A9F-371A-19B1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9109C0C-1CA3-1B33-E053-731AD00AD7D7","beginDate":"2023-04-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-04-11","modifiedBy":"KUMMEROA","dateModified":"2023-04-11","deletedIndicator":"No"},{"value":"Metabolic disease","valueDescription":null,"ValueMeaning":{"publicId":"3876598","version":"1","preferredName":"Metabolic Disorder","longName":"3876598","preferredDefinition":"A congenital (due to inherited enzyme abnormality) or acquired (due to failure of a metabolic important organ) disorder resulting from an abnormal metabolic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metabolic Disorder","conceptCode":"C3235","definition":"A congenital (due to inherited enzyme abnormality) or acquired (due to failure of a metabolic important organ) disorder resulting from an abnormal metabolic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5AA7908-A0D9-DC7A-E040-BB89AD4319DD","latestVersionIndicator":"Yes","beginDate":"2013-09-05","endDate":null,"createdBy":"WONGW","dateCreated":"2013-09-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9109C0C-1CA4-1B33-E053-731AD00AD7D7","beginDate":"2023-04-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-04-11","modifiedBy":"KUMMEROA","dateModified":"2023-04-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2685310","version":"1","preferredName":"Infusion Indication Type","preferredDefinition":"A method of putting fluids, including drugs, into the bloodstream. Also called intravenous infusion.:A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).:Type; a subdivision of a particular kind of thing.","longName":"C15388:C41184:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infusion Procedure","conceptCode":"C15388","definition":"Any form of treatment that is introduced into the body via a blood vessel, a muscle, or the spinal cord.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Indication","conceptCode":"C41184","definition":"A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B9D2D5E-ED2B-03C4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-03","endDate":null,"createdBy":"JOSHUAT","dateCreated":"2007-10-03","modifiedBy":"ONEDATA","dateModified":"2007-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8B057E2-A816-59B1-E053-4EBD850AFE86","latestVersionIndicator":"Yes","beginDate":"2020-06-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-23","modifiedBy":"KUMMEROA","dateModified":"2023-04-11","changeDescription":"Released. 07/30/2020 KMM","administrativeNotes":"2023.4.11 PVs added per ticket request and approval of NMDP. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"IND_TRANSPLANT_TP","type":"COG Form Element","context":"COG"}],"ReferenceDocuments":[{"name":"What is the the primary indic","type":"Preferred Question Text","description":"What is the the primary indication for the hematopoietic cell transplant or cellular therapy infusion?","url":null,"context":"NHLBI"},{"name":"What was the PRIMARY reason for infusion?","type":"Application Standard Question Text","description":"What was the PRIMARY reason for infusion?","url":null,"context":"NHLBI"},{"name":"What was the PRIMARY reason for infusion?","type":"Alternate Question Text","description":"What was the PRIMARY reason for infusion?","url":null,"context":"NHLBI"},{"name":"What was the primary indication for performing treatment with cellular therapy?","type":"Alternate Question Text","description":"What was the primary indication for performing treatment with cellular therapy?","url":null,"context":"NHLBI"},{"name":"NMDP Text","type":"Alternate Question Text","description":"What was the primary indication for performing treatment with donor lymphocyte infusion (DLI)?","url":null,"context":"NHLBI"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Indication for transplant:","url":null,"context":"COG"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8B0409F-0FAD-471B-E053-4EBD850A1366","latestVersionIndicator":"Yes","beginDate":"2020-06-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-06-23","modifiedBy":"KUMMEROA","dateModified":"2023-04-12","changeDescription":"Released 07/31/2020 KMM; System generated def displayed as alt def. 06/23/2020 KMM. AQT added for 2199r1. 04/11/2022 KMM","administrativeNotes":"2023.4.11 AQT/Alt SN added per ticket request CADSR0002291. ak","unresolvedIssues":null,"deletedIndicator":"No"}}